EP2076515 - THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.05.2014 Database last updated on 03.09.2024 | Most recent event Tooltip | 24.07.2015 | Lapse of the patent in a contracting state New state(s): BG, HU, LU | published on 26.08.2015 [2015/35] | Applicant(s) | For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, IN 46285 / US | [2013/29] |
Former [2009/28] | For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis IN 46285 / US | Inventor(s) | 01 /
CHEN, Zhaogen 10532 Titan Run Carmel, Indiana 46032 / US | 02 /
HAMDOUCHI, Chafiq, Hamdouchi 14469 Twin Oaks Drive Carmel, Indiana 46032 / US | 03 /
HEMBRE, Erik, James 1332 North New Jersey Street Indianapolis, Indiana 46202 / US | 04 /
HIPSKIND, Philip, Arthur 4255 Cabin Court New Palestine, Indiana 46163 / US | 05 /
JIA, Shaojuan 3865 Castle Rock Drive Zionsville, Indiana 46077 / US | 06 /
TOTH, James, Lee 4642 South 625 West Knightstown, Indiana 46148 / US | [2009/28] | Representative(s) | Bassinder, Emma Marie Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | [N/P] |
Former [2013/29] | Bassinder, Emma Marie Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road Windlesham, Surrey GU20 6PH / GB | ||
Former [2009/28] | Bassinder, Emma Marie Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road Windlesham, Surrey GU20 6PH / GB | Application number, filing date | 07814842.6 | 13.09.2007 | [2009/28] | WO2007US78352 | Priority number, date | US20060826273P | 20.09.2006 Original published format: US 826273 P | [2009/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008036541 | Date: | 27.03.2008 | Language: | EN | [2008/13] | Type: | A1 Application with search report | No.: | EP2076515 | Date: | 08.07.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.03.2008 takes the place of the publication of the European patent application. | [2009/28] | Type: | B1 Patent specification | No.: | EP2076515 | Date: | 17.07.2013 | Language: | EN | [2013/29] | Search report(s) | International search report - published on: | EP | 27.03.2008 | Classification | IPC: | C07D487/04, A61K31/495, A61P25/24 | [2009/28] | CPC: |
C07D487/04 (EP,KR,US);
A61K31/495 (KR);
A61P1/04 (EP);
A61P15/00 (EP);
A61P15/08 (EP);
A61P15/10 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/32 (EP);
A61P25/36 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P35/00 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/28] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | THIOPHENPYRAZOLOPYRIMIDINVERBINDUNGEN | [2009/28] | English: | THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS | [2009/28] | French: | COMPOSÉS DE THIOPHÈNE PYRAZOLOPYRIMIDINE | [2009/28] | Entry into regional phase | 20.04.2009 | National basic fee paid | 20.04.2009 | Designation fee(s) paid | 20.04.2009 | Examination fee paid | Examination procedure | 02.04.2009 | Amendment by applicant (claims and/or description) | 20.04.2009 | Examination requested [2009/28] | 05.08.2009 | Despatch of a communication from the examining division (Time limit: M04) | 10.12.2009 | Reply to a communication from the examining division | 15.02.2013 | Communication of intention to grant the patent | 31.05.2013 | Fee for grant paid | 31.05.2013 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.08.2009 | Opposition(s) | 22.04.2014 | No opposition filed within time limit [2014/26] | Fees paid | Renewal fee | 30.09.2009 | Renewal fee patent year 03 | 30.09.2010 | Renewal fee patent year 04 | 30.09.2011 | Renewal fee patent year 05 | 01.10.2012 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 13.09.2007 | AT | 17.07.2013 | BE | 17.07.2013 | BG | 17.07.2013 | CY | 17.07.2013 | CZ | 17.07.2013 | DK | 17.07.2013 | EE | 17.07.2013 | FI | 17.07.2013 | LT | 17.07.2013 | LV | 17.07.2013 | MC | 17.07.2013 | MT | 17.07.2013 | NL | 17.07.2013 | PL | 17.07.2013 | RO | 17.07.2013 | SE | 17.07.2013 | SI | 17.07.2013 | SK | 17.07.2013 | TR | 17.07.2013 | IE | 13.09.2013 | LU | 13.09.2013 | CH | 30.09.2013 | LI | 30.09.2013 | GR | 18.10.2013 | IS | 17.11.2013 | PT | 18.11.2013 | [2015/34] |
Former [2015/32] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
CZ | 17.07.2013 | ||
DK | 17.07.2013 | ||
EE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
MT | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
RO | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
SK | 17.07.2013 | ||
TR | 17.07.2013 | ||
IE | 13.09.2013 | ||
CH | 30.09.2013 | ||
LI | 30.09.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/34] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
CZ | 17.07.2013 | ||
DK | 17.07.2013 | ||
EE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
RO | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
SK | 17.07.2013 | ||
IE | 13.09.2013 | ||
CH | 30.09.2013 | ||
LI | 30.09.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/33] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
CZ | 17.07.2013 | ||
DK | 17.07.2013 | ||
EE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
RO | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
SK | 17.07.2013 | ||
IE | 13.09.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/23] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
CZ | 17.07.2013 | ||
DK | 17.07.2013 | ||
EE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
RO | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
SK | 17.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/22] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
DK | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
RO | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/21] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
DK | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/20] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
MC | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/18] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
CY | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/14] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
NL | 17.07.2013 | ||
PL | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
CY | 31.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/12] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
LV | 17.07.2013 | ||
PL | 17.07.2013 | ||
SE | 17.07.2013 | ||
SI | 17.07.2013 | ||
CY | 31.07.2013 | ||
GR | 18.10.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/11] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
FI | 17.07.2013 | ||
LT | 17.07.2013 | ||
PL | 17.07.2013 | ||
SE | 17.07.2013 | ||
CY | 31.07.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/10] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
LT | 17.07.2013 | ||
SE | 17.07.2013 | ||
CY | 31.07.2013 | ||
IS | 17.11.2013 | ||
PT | 18.11.2013 | ||
Former [2014/09] | AT | 17.07.2013 | |
BE | 17.07.2013 | ||
LT | 17.07.2013 | ||
SE | 17.07.2013 | ||
PT | 18.11.2013 | ||
Former [2014/08] | LT | 17.07.2013 | |
PT | 18.11.2013 | Cited in | International search | [Y]WO2005063755 (SB PHARMCO INC [US], et al) [Y] 1-12 * page 1, line 11 - page 3, line 13 * * page 31 - page 32; examples 2-1--2-17 * * claim 1 *; | [DY]WO9729109 (JANSSEN PHARMACEUTICA NV [BE], et al) [DY] 1-12 * page 1, line 5 - page 2, line 36 * * page 20 - page 23; table 4 * * claim 1 *; | [A]WO0123388 (NEUROGEN CORP [US], et al) [A] 1-12 * page 1, line 18 - page 2, line 17 * * Table of examples; page 61 * * claim 1 * | [Y] - MAJO V.J. ET AL, "Facile Palladium-Catalyzed Synthesis of 3-Arylpyrazolo-[1,5a]pyrimidines", ADVANCED SYNTHESIS AND CATALYSIS, WILEY, WEINHEIM, DE, (200305), vol. 345, no. 5, ISSN 1615-4169, pages 620 - 624, XP002468036 [Y] 1-12 * page 1, paragraph 2 * * page 622; table 2; compound 6E * DOI: http://dx.doi.org/10.1002/adsc.200202191 |